Over the last 7 days, the Pharma industry has dropped 3.2%, driven by a pullback from Camurus of 3.7%. In contrast, Infant Bacterial Therapeutics has gained 10%. In the past year, the industry has gained 71%. Looking forward, earnings are forecast to grow by 67% annually.
Has the Swedish Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 07 Aug 2024 | SEK 66.0b | SEK 5.6b | -SEK 992,729,150.10 | 91.8x | -66.5x | 11.8x |
Fri, 05 Jul 2024 | SEK 65.7b | SEK 6.4b | -SEK 862,458,972.59 | 76.1x | -76.1x | 10.3x |
Sun, 02 Jun 2024 | SEK 60.2b | SEK 6.4b | -SEK 766,392,647.41 | 74.3x | -78.6x | 9.5x |
Tue, 30 Apr 2024 | SEK 49.0b | SEK 6.3b | -SEK 919,952,896.39 | 66.3x | -53.3x | 7.8x |
Thu, 28 Mar 2024 | SEK 52.3b | SEK 6.2b | -SEK 1,038,121,333.79 | 76.4x | -50.3x | 8.4x |
Sat, 24 Feb 2024 | SEK 46.9b | SEK 6.2b | -SEK 1,038,154,187.55 | 83.2x | -45.2x | 7.5x |
Mon, 22 Jan 2024 | SEK 68.2b | SEK 9.5b | -SEK 1,182,202,468.00 | 62.3x | -57.7x | 7.2x |
Wed, 20 Dec 2023 | SEK 66.2b | SEK 9.4b | -SEK 1,184,270,720.00 | 62.1x | -55.9x | 7x |
Fri, 17 Nov 2023 | SEK 58.4b | SEK 9.5b | -SEK 1,230,460,773.00 | 93.5x | -47.5x | 6.2x |
Sun, 15 Oct 2023 | SEK 50.9b | SEK 9.2b | -SEK 1,181,419,787.00 | 101.4x | -43.1x | 5.5x |
Tue, 12 Sep 2023 | SEK 50.8b | SEK 9.2b | -SEK 1,177,922,497.00 | 137.5x | -43.1x | 5.5x |
Thu, 10 Aug 2023 | SEK 52.4b | SEK 8.9b | -SEK 1,396,143,356.00 | 87x | -37.5x | 5.9x |
Sat, 08 Jul 2023 | SEK 48.1b | SEK 8.4b | -SEK 1,693,587,846.00 | 76.5x | -28.4x | 5.8x |
Mon, 05 Jun 2023 | SEK 47.9b | SEK 8.4b | -SEK 1,608,786,861.00 | 76.5x | -29.8x | 5.7x |
Wed, 03 May 2023 | SEK 47.8b | SEK 8.1b | -SEK 1,817,450,255.00 | 94.1x | -26.3x | 5.9x |
Fri, 31 Mar 2023 | SEK 44.9b | SEK 8.0b | -SEK 1,793,726,400.00 | 87.7x | -25x | 5.6x |
Sun, 26 Feb 2023 | SEK 44.4b | SEK 8.0b | -SEK 1,783,545,778.00 | 221.7x | -24.9x | 5.5x |
Tue, 24 Jan 2023 | SEK 49.2b | SEK 7.3b | -SEK 1,938,236,159.00 | 297.2x | -25.4x | 6.7x |
Thu, 22 Dec 2022 | SEK 49.0b | SEK 7.3b | -SEK 1,910,488,239.00 | 291x | -25.6x | 6.7x |
Sat, 19 Nov 2022 | SEK 48.8b | SEK 7.1b | -SEK 1,902,904,597.00 | 48.9x | -25.7x | 6.8x |
Mon, 17 Oct 2022 | SEK 49.3b | SEK 7.0b | -SEK 1,754,682,602.00 | 47x | -28.1x | 7.1x |
Wed, 14 Sep 2022 | SEK 52.4b | SEK 7.0b | -SEK 1,737,055,214.00 | 55.1x | -30.1x | 7.5x |
Fri, 12 Aug 2022 | SEK 54.9b | SEK 6.9b | -SEK 1,535,705,660.00 | 41.3x | -35.7x | 8x |
Sun, 10 Jul 2022 | SEK 54.8b | SEK 5.9b | -SEK 1,509,116,648.00 | 41.9x | -36.3x | 9.3x |
Tue, 07 Jun 2022 | SEK 54.2b | SEK 5.9b | -SEK 1,505,666,101.00 | 44.6x | -36x | 9.1x |
Thu, 05 May 2022 | SEK 52.4b | SEK 5.5b | -SEK 1,351,308,728.00 | 36.9x | -38.7x | 9.5x |
Sat, 02 Apr 2022 | SEK 56.0b | SEK 5.4b | -SEK 1,280,292,342.00 | 40x | -43.7x | 10.4x |
Mon, 28 Feb 2022 | SEK 48.9b | SEK 5.4b | -SEK 1,271,467,538.00 | 32.6x | -38.5x | 9x |
Wed, 26 Jan 2022 | SEK 46.4b | SEK 5.5b | -SEK 1,084,301,917.00 | 105x | -42.8x | 8.5x |
Fri, 24 Dec 2021 | SEK 57.0b | SEK 5.5b | -SEK 1,100,261,791.00 | 112.9x | -51.8x | 10.4x |
Sun, 21 Nov 2021 | SEK 58.3b | SEK 5.4b | -SEK 1,056,088,197.00 | 89.1x | -55.2x | 10.7x |
Tue, 19 Oct 2021 | SEK 53.6b | SEK 4.8b | -SEK 1,581,983,841.00 | 157.1x | -33.9x | 11.2x |
Thu, 16 Sep 2021 | SEK 56.0b | SEK 4.8b | -SEK 1,560,489,765.26 | 172.8x | -35.9x | 11.7x |
Sat, 14 Aug 2021 | SEK 54.5b | SEK 4.8b | -SEK 1,412,039,942.26 | 159.4x | -38.6x | 11.4x |
-38.6x
Which industries have driven the changes within the Swedish Healthcare industry?
SE Market | -7.16% | |
Healthcare | -5.25% | |
Pharma | -3.15% | |
Pharma | -3.15% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
IBT B Infant Bacterial Therapeutics | SEK 108.50 | 10.5% +SEK 138.8m | 23.3% | PS21183.3x | |
CESSA Cessatech | DKK 8.40 | 7.7% +DKK 10.5m | 349.2% | PB7.7x | |
CALTX Calliditas Therapeutics | SEK 206.80 | 0.1% +SEK 10.8m | 107.3% | PS8.5x | |
KLAR Klaria Pharma Holding AB (publ.) | SEK 0.36 | 13.3% +SEK 5.4m | -42.1% | PB1.6x | |
EMPLI Emplicure | SEK 0.47 | 9.3% +SEK 4.0m | -68.5% | PB2.2x |